This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackmore, T.
Right arrow Articles by Byrne, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blackmore, T.
Right arrow Articles by Byrne, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 4189-4190, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4189-4190.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Characterization of Prolyl Iminopeptidase-Deficient Neisseria gonorrhoeae

T. Blackmore,1,2* G. Hererra,1 S. Shi,1 P. Bridgewater,3 L. Wheeler,2 and J. Byrne1

Laboratories, Wellington Hospital, Riddiford St., Wellington South, New Zealand,1 Wellington Medical Laboratories, Courtenay Place, Wellington, New Zealand,3 Institute of Environmental Science and Research, 34 Kenepuru Drive, Porirua, New Zealand2

Received 22 March 2005/ Returned for modification 7 May 2005/ Accepted 22 May 2005

Prolyl iminopeptidase (PIP) is an enzyme produced by Neisseria gonorrhoeae, the detection of which is incorporated into several commercial test panels. In this report we describe two distinct mutations in the pip gene which account for the loss of PIP activity.


* Corresponding author. Mailing address: Laboratories, Wellington Hospital, Private Bag 7902, Wellington South, New Zealand. Phone: 64 4 385 5999, ext. 6834. Fax: 64 4 385 5814. E-mail: timothy.blackmore{at}ccdhb.org.nz.


Journal of Clinical Microbiology, August 2005, p. 4189-4190, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4189-4190.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Unemo, M, Palmer, H M, Blackmore, T, Herrera, G, Fredlund, H, Limnios, A, Nguyen, N, Tapsall, J (2007). Global transmission of prolyliminopeptidase-negative Neisseria gonorrhoeae strains: implications for changes in diagnostic strategies. Sex. Transm. Infect. 83: 47-51 [Abstract] [Full Text]  
  • Otero, L, Alvarez-Arguelles, M, Villar, H, Diaz-Gigante, J, Carreno, F, Vazquez, F (2007). The prevalence of Neisseria gonorrhoeae negative for proline iminopeptidase in Asturias, Spain. Sex. Transm. Infect. 83: 76-76 [Full Text]  
  • Alexander, S, Martin, I M C, Fenton, K, Ison, C A (2006). The prevalence of proline iminopeptidase negative Neisseria gonorrhoeae throughout England and Wales.. Sex. Transm. Infect. 82: 280-282 [Abstract] [Full Text]  
  • Limnios, E. A., Nguyen, N.-L., Ray, S., McIver, C. J., Tapsall, J. W. (2006). Dynamics of Appearance and Expansion of a Prolyliminopeptidase- Negative Subtype among Neisseria gonorrhoeae Isolates Collected in Sydney, Australia, from 2002 to 2005. J. Clin. Microbiol. 44: 1400-1404 [Abstract] [Full Text]